Trial Profile
FENOC: The FEIBA NovoSeven Comparative Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2015
Price :
$35
*
At a glance
- Drugs Eptacog alfa (Primary) ; Factor VIII inhibitor bypassing fraction (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms FENOC
- 18 Feb 2015 New trial record